The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids

European Journal of Biochemistry

Volumn 241, Issue 3, 1996, Pages 879-887

  Gallois, Laurence ^a,b   Fiallo, Marina ^a,b   Laigle, Alain ^a,b   Priebe, Waldemar ^c   Garnier Suillerot, Arlette ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Anionic phospholipid; Anthracycline; Membrane; Partition coefficient

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DAUNORUBICINOL; DOXORUBICIN; DOXORUBICINOL; IDARUBICIN; IDARUBICINOL; PIRARUBICIN;

ARTICLE; ARTIFICIAL MEMBRANE; DRUG DISTRIBUTION; HYDROPHOBICITY; IN VITRO STUDY; MEMBRANE TRANSPORT; MICROFLUOROMETRY; MULTIDRUG RESISTANCE; PARTITION COEFFICIENT; PRIORITY JOURNAL;

EID: 0029999977     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.00879.x     Document Type: Article

References (40)

1. Banuelos, S., Arrondo, J. L. R., Canaves, J. M., Ferragut, J. A. & Muga, A. (1993) The interaction of daunomycin with model membranes. Effect of the lipid physical state and the lipid composition, Eur. J. Biochem. 213, 1269-1275.
2. Barchfeld, C. L. & Deamer, D. W. (1988) Alcohol effects on lipid bilayer permeability to protons and potasium: relation to the action of general anesthetics, Biochim. Biophys. Acta 944, 40-48.
3. Beschiaschvili, G. & Seelig, J. (1992) Peptide binding to lipid bilayers. Nonclassical hydrophobic effects and membrane-induced pK shifts, Biochemistry 31, 10044-10053.
4. Booser, D. J. & Hortobagyi, G. N. (1994) Anthracycline antibiotics in cancer therapy. Focus on drug resistance, Drugs 47, 223-258.
5. Bradley, G., Juranka, P. F. & Ling, V. (1988) Mechanism of multidrug resistance, Biochim. Biophys. Acta 948, 87-128.
6. Burke, T. G. & Tritton, T. G. (1985) Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study, Biochemistry 24, 1768-1776.
7. Burke, T. G., Morin, M. J., Sartorelli, A. C., Lane, P. E. & Tritton, T. R. (1987) Function of the anthracycline amino groups in cellular transport and cytotoxicity, Mol. Pharmacol. 31, 552-556.
8. Burke, T. G., Israel, M., Seshadri, R. & Doroshow, J. H. (1989) A fluorescence study examining how 14-valerate side chain substitution modulates anthracycline binding to small unilamellar phospholipid vesicles, Biochim. Biophys. Acta 982, 123-130.
9. Burke, T. G., Israel, M., Seshadri, R. & Doroshow, J. H. (1990) Abrogation of the selectivity of adriamycin for negatively-charged phospholipids by 14-valerate side chain substitution, Cancer Biochim. Biophys. 11, 177-185.
10. Coley, H. M., Twentyman, P. R. & Workman, P. (1989) Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A, Biochem. Pharmacol. 38, 4467-4475.
11. De Wolf, F. A., Maliepaard, M., Van Dorsten, F., Berghuis, I., Nicolay, K. & de Kruijff, B. (1991a) Comparable interaction of doxorubicin with various acidic phospholipids results in changes in lipid order and dynamics, Biochim. Biophys. Acta 1096, 67-80.
12. De Wolf, F. A. (1991b) Binding of doxorubicin to cardiolipin as compared to other anionic phospholipids. An evaluation of electrostatic effects, Biosci. Rep. 11, 275-284.
13. De Wolf, F. A., Nicolay, K. & de Kruijff, B. (1992) Effect of doxorubicin on the order of the acyl chains of anionic and zwitterionic phospholipids in liquid-crytalline mixed model membranes: Absence of drug-induced segregation of lipids into extended domains, Biochemistry 31, 9252-9262.
14. De Wolf, F. A., Staffhorst, R. W. H. M., Smits, H. P., Onwezen, M. F. & de Kruijff, B. (1993) Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: Drug binding and structural consequences in bacterial systems, Biochemistry 32, 6688-6695.
15. Dupou-Cezanne, L., Santereau, A. M. & Tocanne, J. F. (1989) Localization of adriamycin in model and natural membrane. Influence of lipid molecular packing, Eur. J. Biochem. 181, 695-702.
16. Frezard, F. & Garnier-Suillerot, A. (1990) Comparison of the binding of anthracycline derivatives to purified DNA and cell nuclei, Biochim. Biophys. Acta 1036, 121-127.
17. Frezard, F. & Garnier-Suillerot, A. (1991a) Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells, Eur. J. Biochem. 196, 483-491.
18. Frezard, F. & Garnier-Suillerot, A. (1991b) DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives, Biochemistry 30, 5038-5043.
19. Frezard, F. & Garnier-Suillerot, A. (1991c) Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells, Biochim. Biophys. Acta 1091, 29-35.
20. Garnier-Suillerot, A. & Gattegno, L. (1988) Interaction of adriamycin with human erythrocyte membranes. Role of the negatively charged phospholipids, Biochim. Biophys. Acta 936, 50-60.
21. Garnier-Suillerot, A. (1995) Impaired acumulation of drug in multidrug resistant cells. What are the respective contributions of the kinetics of uptake and of P-glycoprotein-mediated efflux of drug? Current Pharmaceutical Design 1, 69-82.
22. Goldman, R., Facchinetti, T., Bach, D., Raj, A. & Shinitzky, M. (1978) A differential interaction of daunomycin adriamycin and their derivatives with human erythrocytes and phospholipid bilayer, Biochim. Biophys. Acta 512, 254-269.
23. Goormaghtigh, K., Chatelain, P., Caspers, J. & Ruysschaert, J. M. (1980) Evidence of a specific complex between adriamycin and negatively-charged phospholipids, Biochim. Biophys. Acta 597, 1-14.
24. Goormaghtigh, E., Brasseur, R., Huart, P. & Ruysschaert, J. M. (1987) Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy, Biochemistry 26, 1789-1794.
25. Gottesman, M. M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem. 62, 385-427.
26. Henry, N., Fantine, E., Bolard, J. & Garnier-Suillerot, A. (1985) Interaction of adriamycin with negatively charged-model membranes: Evidence of two types of binding sites, Biochemistry 24, 7085-7092.
27. Henry-Toulmé, N., Stefanska, B., Borowski, E. & Bolard, J. (1988) Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: Circular dichroism studies, Mol. Pharmacol. 33, 574-579.
28. Horton, D., Priebe, W. & Varela, O. (1984) Synthesis and antitumor activity of 3′-deamino-3′-hydroxydoxorubicin: A facile procedure for the preparation of doxorubicin analogs, J. Antibiot. 37, 1635-1641.
29. Mankhetkorn, S., Dubru, F., Hesschenbrouck, J., Fiallo, M. & Garnier-Suillerot, A. (1996) Relation among the resistance factor, the kinetics of uptake and the kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin and idarubicin in multidrug resistant K562 cells, Mol. Pharmacol. 49, 532-539.
30. Marshall Stewart, J. M. (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate, Anal. Biochim. 104, 10-14.
31. Pereira, E. & Garnier-Suillerot, A. (1994) Correlation between the short-term measurements of drug accumulation in living cells and the long-term growth inhibition, Biochem. Pharmacol. 47, 1851-1857.
32. Priebe, W. (1995) Mechanism of action-governed design of anthracycline antibiotics: a 'turn-off/turn-on' approach, Curr. Pharm. Des. 1, 51-68.
33. Rekker, R. F. (1977) The hydrophobic fragmental. Its derivation and applications. A means of characterizing membrane systems, Pharmacochemistry Library (vol. 1), Elsevier, Amsterdam.
34. Skovsgaard, T. & Nissen, N. I. (1982) Membrane transport of anthracyclines, Pharmac. Ther. 18, 293-311.
35. Speelmans, G., Staffhorst, R. W. H. M., de Kruijff, B. & de Wolf, F. (1994) Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane, Biochemistry 33, 13761-13768.
36. Subczynski, W., Wisniewska, A., Yin, J. J., Hyde, J. S. & Kusumi, A. (1994) Hydrophobic barriers of lipid bilayer membranes formed by reduction of water penetration by alkyl chain unsaturation and cholesterol, Biochemistry 33, 7670-7681.
37. Sureau, F., Chinsky, L., Dusquesne, M., Laigle, A., Turpin, P. Y., Amirand, C., Ballini, J. P. & Vigny, P. (1990) Microspectrofluorometric study of the kinetics of cellular uptake and metabolization of benzo [a] pyrene in human T47D mammary tumor cells: evidence for cytochrome P-450 induction, Eur. Biophys. J. 18, 1707-1713.
38. Szoka, F., Olson, F., Heath, T., Voul, W., Mayhew, E. & Papahadjopoulos, D. (1980) Preparation of unilamellar liposomes of intermediate size (0.1-0.2 μm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes, Biochim. Biophys. Acta 601, 559-567.
39. Tapiero, H., Munck, J. N. & Fourcade, A. (1986) Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo, Drugs Exp. Clin. Res. 12, 257-264.
40. Van de Waterbeemd, H. & Testa, B. (1987) Parametrization of lipophilicity, Adv. Drug Res. 16, 87-210.